Predictors of Three Dose On-Time Compliance with HPV4 Vaccination in a Disadvantaged, Underserved, Safety Net Population in the US Midwest

BACKGROUND: HPV4 is approved as a series of three timed doses expected to result in efficacy against specific HPV infections. Completion rates in the US are quite low at the same time the structure of health care delivery is changing. The aim of this study was to determine how the patient-, clinic-...

Descripción completa

Detalles Bibliográficos
Autores principales: Verdenius, Inge, Harper, Diane M., Harris, George D., Griffith, R. Stephen, Wall, Jeffrey, Hempstead, Laura K., Malnar, Gerard J., Bekkers, Ruud L. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738587/
https://www.ncbi.nlm.nih.gov/pubmed/23951123
http://dx.doi.org/10.1371/journal.pone.0071295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738587/
https://www.ncbi.nlm.nih.gov/pubmed/23951123
http://dx.doi.org/10.1371/journal.pone.0071295

Ejemplares similares